QR code

A gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: a double-blind, randomized, phase 1 study in Switzerland

Abstract Background New vaccines with broader protection against SARS-CoV-2 are needed to reduce the risk of immune escape and provide broad and long-lasting cellular immunity. The objectives of the naNO-COVID trial were to evaluate the safety and immunogenicity of a CD8 + T cell, gold nanoparticle-...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Juliette Besson, Régine Audran, Maxime Karlen, Alix Miauton, Hélène Maby-El Hajjami, Loane Warpelin-Decrausaz, Loredana Sene, Sylvain Schaufelberger, Vincent Faivre, Mohamed Faouzi, Mary-Anne Hartley, François Spertini, Blaise Genton
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BMC 2025-04-01
Reeks:BMC Infectious Diseases
Onderwerpen:
COVID-19
SARS-CoV-2
Vaccine
Nanoparticle
Cellular
Immunity
Online toegang:https://doi.org/10.1186/s12879-025-10844-3
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items